TenSixteen Bio launches a $40M Series A To Prove A New Approach To Disease Detection and TreatmentBiosciences startup TenSixteen Bio launched Thursday with a $40 million Series A round funded by Foresite Capital and GV, formerly Google Ventures..#Chief Technology Officer·chieftechnologyofficer.blog·Mar 6, 2022TenSixteen Bio launches a $40M Series A To Prove A New Approach To Disease Detection and Treatment